MEDIA

EVENTS

Repurposing represents an emerging and dynamic drug development strategy, particularly in settings with unmet therapeutic needs. This was the key topic addressed by renowned experts in the field during the XVI Foresight Training Course “Repurposing to cover unmet needs: the current scenario in Europe and the proposed changes to the pharmaceutical legislation”, organised on 18 December by Fondazione Gianni Benzi in cooperation with Università degli Studi di Bari.

More than 170 attendees participated in the event both face to face in Bari and online.

It was a successful opportunity to share experiences and concerns about repurposing, stimulating exciting discussions among all the stakeholders involved in the repurposing pathway, such as representatives of academia, companies, the European Medicines Agency and patients.

The meaning of repurposing in the paediatric and rare diseases settings to meet therapeutic needs was widely discussed during the Course. Moreover, specific repurposing collaborative approaches and strategies implemented by companies and academic research groups were well presented with a focus on innovative tools potentially supporting the generation of evidence for the drug development, such as in-silico modelling and extrapolation approaches.

The Course also made room to the voice of patients about repurposing, including their issues and concerns as well as the need for the engagement of patients in the framework of this promising opportunity for them.

In addition, we had the chance to share thoughts and debate the possible impact of changes proposed by the European Commission to the Pharmaceutical Legislation on repurposing approaches.

Go deeper into the topics addressed during the Course here!

If you were unable to join us, you can find the videorecording on our website.

Looking forward to the next Foresight Training Course in 2024!

Subscribe To Our Newsletter

to keep you up to date on our activities and initiatives

La tua iscrizione non può essere convalidata.
La tua iscrizione è avvenuta correttamente.

We use Brevo as our marketing platform. By clicking below to submit this form, you are aware and accept that the information you have provided will be transferred to Brevo for treatment in accordance with their terms of use
Utilizziamo Brevo come nostra piattaforma di marketing. Cliccando qui sotto per inviare questo modulo, sei consapevole e accetti che le informazioni che hai fornito verranno trasferite a Brevo per il trattamento conformemente alle loro condizioni d'uso

You have Successfully Subscribed!

Pin It on Pinterest

Share This